AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.5 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

A Giant Magnetoimpedance-Based Microfluidic System for Multiplex Immunological Assay

Shan Gao1Lin Kang1Min Deng2Bin Ji1Jing Liu1Wenwen Xin1Jingjing Kang1Ping Li1Jie Gao1Jinglin Wang1( )Hao Yang1( )
State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, No. 21 Dongda Street, Beijing 100071, China
Department of Nano Biomedicine and Engineering, Key Laboratory for Thin Film and Microfabrication of Ministry of Education, Institute of Micro/Nano Science and Technology,Shanghai Jiao Tong University, 800 Dong Chuan Road, Shanghai 200240, China

Shan Gao, Lin Kang and Min Deng contributed equally to this work.

Show Author Information

Abstract

Microfluidic chip and giant magnetoimpedance (GMI)-related technology has developed quickly over the past decades in the field of biological detection. In this work, we designed and fabricated a GMI-based microfluidic system for screening of multiplex gastric cancer biomarkers. The microfluidic chip and GMI sensor were prepared by micro-electromechanical systems (MEMS) technology. This system can analyse 8 gastric cancer protein biomarkers simultaneously in less than 25 mins and offer more stable detection signal than conventional enzymological or fluorescent methods. The microfluidic chip was then tested in 150 clinical specimens and compared with enzyme-linked immunosorbent assay (ELISA) method. The results indicated no significant difference and excellent agreement. In short, the prototype of GMI-based microfluidic system has been developed successfully and showed promising potentials for parallel screening of cancer biomarkers.

References

[1]

L. Chen, C. Bao, H. Yang, et al., A prototype of giant magnetoimpedance-based biosensing system for targeted detection of gastric cancer cells. Biosensors & Bioelectronics, 2011, 26: 3246-3253.

[2]

Y. Xie, X. Zhi, H. Su, et al., A novel electrochemical microfluidic chip combined with multiple biomarkers for early diagnosis of gastric cancer. Nanoscale Research Letters, 2015, 10: 477.

[3]

H. Yang, M. Deng, S. Ga, et al., Capillary-driven surface-enhanced raman scattering (sers)-based microfluidic chip for abrin detection. Nanoscale Research Letters, 2014, 9: 138.

[4]

X. Zhi, M. Deng, H. Yang, et al., A novel HBV genotypes detecting system combined with microfluidic chip, loop-mediated isothermal amplification and gmr sensors. Biosensors & Bioelectronics, 2014, 54: 372-377.

[5]

X. Zhi, Q. Liu, X. Zhang, et al., Quick genotyping detection of HBV by giant magnetoresistive biochip combined with PCR and line probe assay. Lab on a Chip, 2012, 12: 741-745.

[6]

L.V. Panina, K. Mohri, Magneto-impedance effect in amorphous wires. Applied Physics Letters, 1994, 65: 1189.

[7]

H. Yang, L. Chen, C. Lei, et al., Giant magnetoimpedance-based microchannel system for quick and parallel genotyping of human papilloma virus type 16/18. Applied Physics Letters, 2010, 97: 043702.

[8]

Z. Yang, X.-C. Sun, T. Wang, et al., A giant magnetoimpedance-based biosensor for sensitive detection of escherichia coli O157:H7. Biomedical Microdevices, 2015, 17: 5.

[9]

H. Hu, H. Yang, D. Li, et al., The potential of magnetic nanocluster and dual-functional protein-based strategy for noninvasive detection of HBV surface antibodies. The Analyst, 2011, 136: 679-683.

[10]

J. Razumovitch, K. de Franca, F. Kehl, et al., Optimal hybridization efficiency upon immobilization of oligonucleotide double helices. The Journal of Physical Chemistry B, 2009, 113: 8383-8390.

[11]

T.-H. Zheng, J.-L. Zhao, B. Guleng. Advances in molecular biomarkers for gastric cancer. Critical Reviews in Eukaryotic Gene Expression, 2015, 25: 299-305.

[12]

A.P. Yang, J. Liu, H.Y. Lei, et al., CA72-4 combined with cea, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer. Clinica Chimica Acta, 2014, 437: 183-186.

[13]

R. Kikuchi, Y. Abe, K. Iijima, et al., Low serum levels of pepsinogen and gastrin 17 are predictive of extensive gastric atrophy with high-risk of early gastric cancer. The Tohoku Journal of Experimental Medicine, 2011, 223: 35-44.

[14]

F. Nejadi-Kelarijani, G. Roshandel, S. Semnani, et al., Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern iran. Asian Pacific Journal of Cancer Prevention, 2014, 15: 7433-7436.

[15]

L. Wang, Y. Chang, J. Xu, et al., Predictive significance of serum level of vascular endothelial growth factor in gastric cancer patients. BioMed Research International, 2016, 2016: 8103019.

Nano Biomedicine and Engineering
Pages 240-245
Cite this article:
Gao S, Kang L, Deng M, et al. A Giant Magnetoimpedance-Based Microfluidic System for Multiplex Immunological Assay. Nano Biomedicine and Engineering, 2016, 8(4): 240-245. https://doi.org/10.5101/nbe.v8i4.p240-245

400

Views

16

Downloads

6

Crossref

7

Scopus

Altmetrics

Received: 16 October 2016
Accepted: 10 November 2016
Published: 23 November 2016
© 2016 Shan Gao, Lin Kang, Min Deng, Bin Ji, Jing Liu, Wenwen Xin, Jingjing Kang, Ping Li, Jie Gao, Jinglin Wang, and Hao Yang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return